Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study

Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy

(2010) F. Persson et al.   DIABETES CARE

Efficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials

(2009) Jun Cheng et al.   AMERICAN JOURNAL OF NEPHROLOGY

The Sudden Demise of Dual Renin-Angiotensin System Blockade or the Soft Science of the Surrogate End Point

(2009) Franz H. Messerli   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-term study of mycophenolate mofetil treatment in IgA nephropathy

(2009) Sydney C.W. Tang et al.   KIDNEY INTERNATIONAL

Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats

(2008) David L. Feldman et al.   HYPERTENSION

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy

(2008) K. N. Lai et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

(2008) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE